A molecular compound developed by Saint Louis University scientists restored learning, memory and appropriate behavior in a mouse model of Alzheimer’s disease, according to findings in the May issue of the Journal of Alzheimer’s Disease.
The molecule also reduced inflammation in the part of the brain responsible for learning and memory.
The paper, authored by a team of scientists led by Susan Farr, Ph.D., research professor of geriatrics at Saint Louis University, is the second mouse study that supports the potential therapeutic value of an antisense compound in treating Alzheimer’s disease in humans.
“It reversed learning and memory deficits and brain inflammation in mice that are genetically engineered to model Alzheimer’s disease,” Farr said. “Our current findings suggest that the compound, which is called antisense oligonucleotide (OL-1), is a potential treatment for Alzheimer’s disease.”
Farr cautioned that the experiment was conducted in a mouse model. Like any drug, before an antisense compound could be tested in human clinical trials, toxicity tests need to be completed.
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- Alzheimer’s/Dementia-Friendly “Happy Thanksgiving” during COVID-19on November 23, 2020 at 4:08 pm
With the numerous COVID-19 impacts, people with a loved one with Alzheimer’s or Dementia have even more adjustments to consider. With limits on in-person gatherings on Thanksgiving and beyond to ...
- New connection between Alzheimer's dementia and Dlgap2on November 23, 2020 at 2:44 pm
A research team has discovered that Dlgap2, a gene that helps facilitate communication between neurons in the nervous system, is associated with the degree of memory loss in mice and risk for ...
- Her husband had Alzheimer's and COVID-19. She couldn't be there with him as he died.on November 23, 2020 at 2:28 pm
After months of being separated from her husband Melanie Zeiger was thrilled to move Jerry into adult foster care, but then COVID-19 hit.
- JAX, UMaine-lead team discover new connection between Alzheimer's dementia and Dlgap2on November 23, 2020 at 12:59 pm
A national research team led by The Jackson Laboratory and the University of Maine discovered that Dlgap2, a gene that helps facilitate communication between neurons in the nervous system, is ...
- Ten tips for reducing risks of Alzheimer's disease, dementia | Mahoneyon November 23, 2020 at 9:24 am
A recent study concluded that people can reduce their risk of cognitive decline and dementia by making positive lifestyle changes.
- Early signs of Alzheimer's disease in people with Down's syndromeon November 23, 2020 at 9:15 am
Researchers at Karolinska Institutet in Sweden have studied the incidence and regional distribution of Alzheimer's disease biomarkers in the brains of people with Down's syndrome. The results can ...
- The loss of a father: A photographer grapples with the legacy of Alzheimer’s diseaseon November 23, 2020 at 7:00 am
When Jalal Shamsazaran photographed his father’s struggle with Alzheimer’s disease, he did it with the expectation that he might, one day, experience it himself.
- NC State's brain implant could be big step in battle against Parkinson's, Alzheimer'son November 23, 2020 at 4:47 am
Researchers at N.C. State say they've developed a chip that can be surgically implanted in the brain to read neural signals and even deliver electric shocks – potentially paving the way for treatments ...
- Diagnosed at 54, he fights to keep Alzheimer’s fade away | Charlotte Observeron November 22, 2020 at 7:16 pm
The distractions of everyday life can make everyone forgetful at times, and Phil Gutis knows that all too well.
- Team discovers new connection between Alzheimer's dementia and Dlgap2on November 22, 2020 at 4:00 pm
A gene known for helping facilitate communication between neurons in the nervous system has been discovered to be connected with Alzheimer's dementia and cognitive decline, according to a national ...
via Bing News